Phase I study of ifosfamide/doxorubicin in metastatic breast cancer.

被引：0
|
作者：
Aziz, Z [1 ]
Sana, S [1 ]
Sherazi, J [1 ]
Ilyas, N [1 ]
机构：
[1] Allama Iqbal Med Coll, Dept Oncol, Lahore, Pakistan
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
153
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [21] Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer
    Rivera, E
    Valero, V
    Syrewicz, L
    Rahman, Z
    Esteva, FL
    Theriault, RL
    Rosales, MM
    Booser, D
    Murray, JL
    Bast, RC
    Hortobagyi, GN
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) : 1716 - 1722
  • [22] Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer
    Holmes, FA
    Madden, T
    Newman, RA
    Valero, V
    Theriault, RL
    Fraschini, G
    Walters, RS
    Booser, DJ
    Buzdar, AU
    Willey, J
    Hortobagyi, GN
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) : 2713 - 2721
  • [23] Phase II study of weekly pegylated liposomal doxorubicin and docetaxel as first-line chemotherapy for metastatic breast cancer.
    Holmes, F
    Blum, JL
    Kruger, S
    Ratnam, S
    Liu, L
    Boehm, KA
    Asmar, L
    O'Shaughnessy, JA
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S130 - S130
  • [24] Phase I study of pegylated liposomal doxorubicin in combination with ifosfamide in pretreated ovarian cancer patients
    Bourgeois, Hugues
    Joly, Florence
    Pujade-Lauraine, Eric
    Cure, Herve
    Guastalla, Jean Paul
    Ferru, Aurelie
    Chabrun, Virginie
    Chieze, Stephanie
    Tourani, Jean-Marc
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (04): : 399 - 404
  • [25] Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS)
    Revathi Suppiah
    Laura Wood
    Paul Elson
    George T. Budd
    Investigational New Drugs, 2006, 24 : 509 - 514
  • [26] Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS).
    Suppiah, R
    Budd, GT
    Wood, L
    Elson, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 831S - 831S
  • [27] Clinical phase-I and pharmacokinetic study with liposomal doxorubicin (DL-1) in patients with advanced metastatic cancer.
    Mross, K
    Gierlich, T
    Zigler-Widmer, G
    Häring, B
    März, W
    Sauer, U
    Eibl, H
    Unger, C
    ANNALS OF ONCOLOGY, 2000, 11 : 137 - 137
  • [28] Phase II of doxorubicin taxol in metastatic breast cancer
    Pazos, C
    Mickiewicz, E
    Di Notto, MR
    Cóppola, F
    Ventriglia, M
    Jovtis, S
    Balbiani, L
    Lewi, D
    Róndinón, M
    Témperley, G
    Trigo, M
    Bertoncín, AM
    Pascual, M
    Uranga, G
    Cazap, E
    Breier, S
    Grasso, S
    Estévez, R
    Triguboff, E
    Alvarez, A
    Suárez, A
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 55 (01) : 91 - 96
  • [29] Phase II of doxorubicin/taxol in metastatic breast cancer
    Claudia Pazos
    Elizabeth Mickiewicz
    María Rosa Di Notto
    Federico Cóppola
    Mónica Ventriglia
    Silvia Jovtis
    Luis Balbiani
    Daniel Lewi
    Mónica Róndinón
    Guillermo Témperley
    Mariana Trigo
    Ana María Bertoncín
    María Pascual
    Graciela Uranga
    Eduardo Cazap
    Simónla Breier
    Sergio Grasso
    Roberto Estévez
    Eduardo Triguboff
    Ana Alvarez
    Albertoi Suárez
    Breast Cancer Research and Treatment, 1999, 55 : 91 - 96
  • [30] Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS)
    Suppiah, Revathi
    Wood, Laura
    Elson, Paul
    Budd, George T.
    INVESTIGATIONAL NEW DRUGS, 2006, 24 (06) : 509 - 514
12345